ClinicalTrials.govpublic full text
A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies
relapsed/refractory advanced solid tumors, relapsed/refractory diffuse large b-cell lymphoma, relapsed/refractory myelodysplasia, relapsed/refractory myelofibrosis, adenoid cystic carcinoma, relapsed/refractory mantle cell lymphoma, relapsed/refractory acute myeloid leukemia, refractory chronic myelomonocytic leukemia, prmt5, prmt5 inhibitor, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 884447
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.